Page 801 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

8 References

234. Gibot S, Cravoisy A, Dupays R, et al. Combined measurement 251. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal
of procalcitonin and soluble TREM-1 in the diagnosis of noso- management therapy for Pseudomonas aeruginosa ventilator-
comial sepsis. Scand J Infect Dis. 2007;39:604-608. associated pneumonia: an observational, multicenter study
235. Horonenko G, Hoyt JC, Robbins RA, et al. Soluble triggering comparing monotherapy with combination antibiotic therapy.
receptor expressed on myeloid cell-1 is increased in patients Crit Care Med. 2007.
with ventilator-associated pneumonia: a preliminary report. 252. Kumar A. Early antimicrobial therapy in severe sepsis and
Chest. 2007;132:58-63. septic shock. Curr Infect Dis Rep. 2010;12:336-344.
236. Flanagan PG, Jackson SK, Findlay G. Diagnosis of gram nega- 253. Martinez JA, Cobos-Trigueros N, Soriano A, et al. Influence
tive, ventilator associated pneumonia by assaying endotoxin in of empiric therapy with a beta-lactam alone or combined
bronchial lavage fluid. J Clin Pathol. 2001;54:107-110. with an aminoglycoside on prognosis of bacteremia due to
237. Kollef MH, Eisenberg PR, Ohlendorf MF, Wick MR. The accu- gram-negative microorganisms. Antimicrob Agents Chemother.
racy of elevated concentrations of endotoxin in bronchoalveolar 2010;54:3590-3596.
lavage fluid for the rapid diagnosis of gram-negative pneumo- 254. Hospital-acquired pneumonia in adults: diagnosis, assessment of
nia. Am J Respir Crit Care Med. 1996;154:1020-1028. severity, initial antimicrobial therapy, and preventive strategies.
238. Nys M, Ledoux D, Canivet JL, De Mol P, Lamy M, Damas P. A consensus statement, American Thoracic Society, November
Correlation between endotoxin level and bacterial count in 1995. Am J Respir Crit Care Med. 1996;153:1711-1725.
bronchoalveolar lavage fluid of ventilated patients. Crit Care 255. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J,
Med. 2000;28:2825-2830. Gibert C. Pseudomonas aeruginosa ventilator-associated pneu-
239. Pugin J, Auckenthaler R, Delaspre O, van Gessel E, Suter PM. monia: comparison of episodes due to piperacillin-resistant
Rapid diagnosis of gram negative pneumonia by assay of endo- versus piperacillin-susceptible organisms. Clin Infect Dis.
toxin in bronchoalveolar lavage fluid. Thorax. 1992;47:547-549. 2002;34:1047-1054.
240. Baker AM, Bowton DL, Haponik EF. Decision making in noso- 256. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence
comial pneumonia. An analytic approach to the interpretation of antibiotic-resistant Pseudomonas aeruginosa: comparison
of quantitative bronchoscopic cultures. Chest. 1995;107:85-95. of risks associated with different antipseudomonal agents.
241. Sterling TR, Ho EJ, Brehm WT, Kirkpatrick MB. Diagnosis Antimicrob Agents Chemother. 1999;43:1379-1382.
and treatment of ventilator-associated pneumonia—impact on 257. Bhat S, Fujitani S, Potoski BA, et al. Pseudomonas aeruginosa
survival. A decision analysis. Chest. 1996;110:1025-1034. infections in the Intensive Care Unit: can the adequacy of
242. Sole Violan J, Fernandez JA, Benitez AB, Cardenosa Cendrero empirical beta-lactam antibiotic therapy be improved? Int J
JA, Rodriguez de Castro F. Impact of quantitative invasive diag- Antimicrob Agents. 2007;30:458-462.
nostic techniques in the management and outcome of mechani- 258. Michel F, Franceschini B, Berger P, et al. Early antibiotic
cally ventilated patients with suspected pneumonia. Crit Care treatment for BAL-confirmed ventilator-associated pneumo-
Med. 2000;28:2737-2741. nia: a role for routine endotracheal aspirate cultures. Chest.
243. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strat- 2005;127:589-597.
egies for management of suspected ventilator-associated pneumo- 259. Depuydt P, Blot S, Benoit D, Decruyenaere J. Improving the
nia. A randomized trial. Ann Intern Med. 2000;132:621-630. adequacy of empirical beta-lactam therapy for Pseudomonas
244. Heyland D, Dodek P, Muscedere J, Day A. A randomized trial aeruginosa ventilator-associated pneumonia. Int J Antimicrob
of diagnostic techniques for ventilator-associated pneumonia. Agents. 2008.
N Engl J Med. 2006;355:2619-2630. 260. Leone M, Garcin F, Bouvenot J, et al. Ventilator-associated
245. Bonten MJ, Bergmans DC, Stobberingh EE, et al. Implementation pneumonia: breaking the vicious circle of antibiotic overuse.
of bronchoscopic techniques in the diagnosis of ventilator- Crit Care Med. 2007;35:379-385; quizz 86.
associated pneumonia to reduce antibiotic use. Am J Respir Crit 261. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumo-
Care Med. 1997;156:1820-1824. nia after heart surgery: a prospective analysis and the value of
246. Joffe AR, Muscedere J, Marshall JC, Su Y, Heyland DK. The surveillance. Crit Care Med. 2003;31:1964-1970.
safety of targeted antibiotic therapy for ventilator-associated 262. Hayon J, Figliolini C, Combes A, et al. Role of serial routine
pneumonia: a multicenter observational study. J Crit Care. microbiologic culture results in the initial management of
2008;23:82-90. ventilator-associated pneumonia. Am J Respir Crit Care Med.
247. Shorr AF, Sherner JH, Jackson WL, Kollef MH. Invasive 2002;165:41-46.
approaches to the diagnosis of ventilator-associated pneumonia: 263. Chastre J. Conference summary: ventilator-associated pneumonia.
a meta-analysis. Crit Care Med. 2005;33:46-53. Respir Care. 2005;50:975-983.
248. Gould IM. Antibiotic policies to control hospital-acquired 264. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized
infection. J Antimicrob Chemother. 2008;61:763-765. controlled trial of an antibiotic discontinuation policy for
249. Yu VL, Singh N. Excessive antimicrobial usage causes mea- clinically suspected ventilator-associated pneumonia. Chest.
surable harm to patients with suspected ventilator-associated 2004;125:1791-1799.
pneumonia. Intensive Care Med. 2004. 265. Niederman MS. The importance of de-escalating antimicro-
250. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short- bial therapy in patients with ventilator-associated pneumonia.
course empiric antibiotic therapy for patients with pulmonary Semin Respir Crit Care Med. 2006;27:45-50.
infiltrates in the intensive care unit. A proposed solution for 266. File TM Jr. Recommendations for treatment of hospital-acquired
indiscriminate antibiotic prescription. Am J Respir Crit Care and ventilator-associated pneumonia: review of recent interna-
Med. 2000;162:505-511. tional guidelines. Clin Infect Dis. 2010;51(suppl 1):S42-S47.

Section04-O-ref.indd 8 1/21/2015 11:23:25 AM